Show simple item record

dc.contributor.authorSaunders, Mark P
dc.contributor.authorValle, Juan W
dc.date.accessioned2009-09-07T10:28:12Z
dc.date.available2009-09-07T10:28:12Z
dc.date.issued2002-06-05
dc.identifier.citationWhy hasn't the National Institute been 'NICE' to patients with colorectal cancer? National Institute of Clinical Excellence. 2002, 86 (11):1667-9 Br. J. Canceren
dc.identifier.issn0007-0920
dc.identifier.pmid12087447
dc.identifier.doi10.1038/sj.bjc.6600369
dc.identifier.urihttp://hdl.handle.net/10541/79993
dc.language.isoenen
dc.subjectColorectal Canceren
dc.subject.meshAntineoplastic Agents
dc.subject.meshAttitude to Health
dc.subject.meshColorectal Neoplasms
dc.subject.meshCross-Over Studies
dc.subject.meshGovernment Agencies
dc.subject.meshGreat Britain
dc.subject.meshHumans
dc.subject.meshRandomized Controlled Trials as Topic
dc.subject.meshResearch Design
dc.titleWhy hasn't the National Institute been 'NICE' to patients with colorectal cancer? National Institute of Clinical Excellence.en
dc.typeArticleen
dc.identifier.journalBritish Journal of Canceren


This item appears in the following Collection(s)

Show simple item record